Helicobacter pylori infection as a possible risk factor for respiratory system disease: A review of the literature

Respiratory Medicine

Volumn 101, Issue 2, 2007, Pages 203-209

  Kanbay, Mehmet ^a   Kanbay, Asiye ^b   Boyacioglu, Sedat ^c  

^a FATIH UNIVERSITY MEDICAL SCHOOL   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

^c Mesa Hospital   (Turkey)

Author keywords

Asthma; Bronchiectasis; Chronic bronchitis; Helicobacter pylori; Lung cancer; Tuberculosis

Indexed keywords

BACTERIUM ANTIBODY; CAGA PROTEIN; CYCLOOXYGENASE 2; GAMMA INTERFERON; GASTRIN; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 1; INTERLEUKIN 8; LEUKOTRIENE C4; THROMBOCYTE ACTIVATING FACTOR; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA; VACUOLATING TOXIN;

ASTHMA; BACTERIAL VIRULENCE; BRONCHIECTASIS; CHRONIC BRONCHITIS; DISEASE ASSOCIATION; ERADICATION THERAPY; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; INFECTION SENSITIVITY; LUNG CANCER; LUNG CARCINOGENESIS; LUNG TUBERCULOSIS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFLAMMATION; REVIEW; RISK FACTOR;

ASTHMA; BRONCHIECTASIS; BRONCHITIS; CHRONIC DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LUNG NEOPLASMS; RESPIRATORY TRACT DISEASES; RISK FACTORS; TUBERCULOSIS, PULMONARY;

EID: 33846181968     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2006.04.022     Document Type: Review

References (60)

1. Megraud F. Eidemiology of Helicobacter pylori infection. Gastroenterol Clin North Am 22 (1993) 73-88
2. Armstrong J.A., McGechie D.B., and Glancy R.J. Campylobacter infection and gastroduodenal disease. Med J Aust 142 (1985) 436-439
3. Macarthur C., Saunders N., and Feldman W. Helicobacter pylori, gastroduodenal disease and recurrent abdominal pain in children. JAMA 273 (1995) 729-734
4. Wotherspoon A.C. Gastric lymphoma of mucosa associated lymphoid tissue and Helicobacter pylori. Annu Rev Med 49 (1998) 289-299
5. Xue F.B., Xu Y.Y., Wan Y., Pan B.R., Ren J., and Fan D.M. Association of H. pylori infection with gastric carcinoma. A meta analysis. World J Gastroenterol 7 (2001) 801-804
6. Perri F., Clemente R., Festa V., et al. Serum tumour necrosis factor-alpha is increased in patients with Helicobacter pylori infection and CagA antibodies. Ital J Gastroenterol Hepatol 31 (1999) 290-294
7. Russo F., Jirillo E., Clemente C., et al. Circulating cytokines and gastrin levels in asymptomatic subjects infected by Helicobacter pylori (H. pylori). Immunopharmacol Immunotoxicol 23 (2001) 13-24
8. Kountouras J., Boura P., and Lygidakis N.J. Omeprazole and regulation of cytokine profile in Helicobacter pylori-infected patients with duodenal ulcer disease. Hepatogastroenterology 47 (2000) 1301-1304
9. Realdi G., Dore M.P., and Fastame L. Extradigestive manifestations of H. pylori infection: fact and fiction. Dig Dis Sci 44 (1999) 229-236
10. Xiang Z., Censini S., Bayeli P.F., Telford J.L., Figura N., Rappuoli R., et al. Analysis of expression of CagA and VacA virulence factor in 43 strains of H. pylori reveals that the clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating toxin. Infect Immun 63 (1995) 94-98
11. Gasbarrini A., Franceschi F., Armuzzi A., Ojetti V., Candelli M., Sanz Torre E., et al. Extradigestive manifestations of Helicobacter pylori gastric infection. Gut 45 Suppl. 1 (1999) 9-12
12. Roussos A., Philippou N., and Gourgoulianis K.I. Helicobacter pylori infection and respiratory diseases: a review. World J Gastroenterol 9 (2003) 5-8
13. Cammaroat G., Pasceri V., Gasbarrini A., and Gabarrini G. Helicobacter pylori is an aetiologic factor for ischaemic heart disease: the case against. Digest Liver Dis 32 (2000) 65-68
14. Gasbarrini A., Franceschi F., Gasbarrini G., and Polo P. Extraintestinal pathology associated with Helocobacter infection. Eur J Gastroenterol Hepatol 9 (1997) 231-233
15. Kanbay M., Gur G., Akcay S., and Yilmaz U. Helicobacter pylori seroprevalence in patients with chronic bronchitis. Respir Med 99 (2005) 1213-1216
16. Gasparrini A., Franceshi F., Gsbarrini G., and Polo P. Extragastrointestinal pathology associated with H. pylori infection. Eur J Gastroenterol Hepatol 9 (1997) 231-233
17. Konturek S.J., Konturek P.C., Pieniazek P., and Bielanski W. Role of H. pylori infection in extragastrointestinal disorders. Introductory remarks. J Physiol Pharmacol 50 (1999) 683-694
18. Viskum K. Peptic ulcer and pulmonary disease. Scand J Respir Dis 55 (1974) 284-290
19. Bonnevie O. Causes of death in duodenal and gastric ulcer. Gastroenterology 73 (1977) 1000-1004
20. Hole D.J., Quigley E.M., Gillis C.R., and Watkinson G. Peptic ulcer and cancer. Scand J Gastroenterol 22 (1987) 17-23
21. Moller H., and Toftgaard C. Cancer occurrence in a cohort of patients surgically treated for peptic ulcer. Gut 32 (1991) 740-744
22. Caygill C.P., Knowles R.L., and Hall R. Increased risk of cancer mortality after vagotomy for peptic ulcer: a preliminary analysis. Eur J Cancer Prev 1 (1991) 35-37
23. Svanes C., Lie S.A., Lie R.T., Soreide O., and Svanes K. Causes of death in patients with peptic ulcer perforation: a long-term follow-up study. Scand J Gastroenterol 34 (1999) 18-24
24. Sanduleanu S., Jonkers D., De Bruine A., Hameetemanm W., and Stockbrügger R.W. Double gastric infection with H. pylori and non-H. pylori bacteria during acid suppressive therapy: increase of pro-inflammatory cytokines and development of atrophic gastritis. Aliment Pharmacol Ther 15 (2001) 1163-1175
25. Laheij R.J., Sturkenboom M.C., Hassing R.J., Dieleman J., Stricker B.H., and Jansen J.B. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 292 (2004) 1955-1960
26. International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans vol. 61 (1994), IARC, Lyon, France
27. Lundegardh G., Helmick C., Zack M., and Adami H.O. Mortality among patients with partial gastrectomy for benign ulcer disease. Dig Dis Sci 39 (1994) 340-346
28. Gocyk W., Nikliski T., Olechnowicz H., Duda A., Bielanski W., Konturek P., et al. Helicobacter pylori, gastrin and cyclooxygenase-2 in lung cancer. Med Sci Monit 6 (2000) 1085-1092
29. Ece F., Hatabay N.F., Erdal N., Gedik C., Guney C., and Aksoy F. Does Helicobacter pylori infection play a role in lung cancer?. Respir Med 99 (2005) 1258-1262
30. Zhou Q., Zhang H., Pang X., et al. Pre- and postoperative sequential study on the serum gastrin level in patients with lung cancer. J Surg Oncol 51 (1992) 22-25
31. Dowlati A., Bury T., Corhay J.L., et al. Gastrin levels in serum and bronchoalveolar lavage fluid of patients with lung cancer: comparison with patients with chronic obstructive pulmonary disease. Thorax 51 (1996) 1270-1272
32. Philippou N., Koursarakos P., Anastasakou E., et al. Helicobacter pylori seroprevalence in patients with lung cancer. World J Gastroenterol 10 (2004) 3342-3344
33. Gocyk W., Niklinski T., Olechnowicz H., et al. Helicobacter pylori, gastrin and cyclooxygenase-2 in lung cancer. Med Sci Monit 6 (2000) 1085-1092
34. Rehfeld J.F., Bardram L., and Hilsted L. Gastrin in bronchogenic carcinomas: constant expression but variable processing of progastrin. Cancer Res 49 (1989) 2840-2843
35. Gocyk W., Niklinski T., Olechnowicz H., Duda A., Bielanski W., Konturek P.C., et al. Helicobacter pylori, gastrin and cyclooxygenase-2 in lung cancer. Med Sci Monit 6 (2000) 1085-1092
36. Moss S.F. The carcinogenic effect of H. pylori on the epithelial cells. J Physiol Pharmacol 50 (1999) 847-856
37. Arora O.P., Kapoor C.P., and Sobti P. Study of gastroduodenal abnormalities in chronic bronchitis and emphysema. Am J Gastroenterol 50 (1968) 289-296
38. Langman M.J., and Cooke A.R. Gastric and duodenal ulcer and their associated diseases. Lancet 1 (1976) 680-683
39. Kellow J.E., Tao Z., and Piper D.W. Ventilatory function in chronic peptic ulcer. Gastroenterology 91 (1986) 590-595
40. Bonnevie O. Causes of death in duodenal and gastric ulcer. Gastroenterology 73 (1977) 1000-1004
41. Gaselli M., Zaffoni E., Ruina M., Sartori S., Trevisani L., Ciaccia A., et al. Helicobacter pylori and chronic bronchitis. Scand J Gastroenterol 34 (1999) 828-830
42. Rosenstock S.J., Jorgensen T., Andersen L.P., and Bonnevie O. Association of Helicobacter pylori infection with lifestyle, chronic disease, body indices and age at menarche in Danish adults. Scand J Public Health 28 (2000) 32-40
43. Roussos A., Philippou N., Krietsepi V., Anastasakou E., Alepopoulou D., Koursarakos P., et al. H. pylori seroprevalence in patients with chronic obstructive pulmonary disease. Respir Med 99 (2005) 279-284
44. Perri F., Clemente R., Festa V., et al. Serum tumour necrosis factor-alpha is increased in patients with Helicobacter pylori infection and CagA antibodies. Ital J Gastroenterol Hepatol 31 (1999) 290-294
45. Russo F., Jirillo E., Clemente C., et al. Circulating cytokines and gastrin levels in asymptomatic subjects infected by Helicobacter pylori (H. pylori). Immunopharmacol Immunotoxicol 23 (2001) 13-24
46. Kountouras J., Boura P., and Lygidakis N.J. Omeprazole and regulation of cytokine profile in Helicobacter pylori-infected patients with duodenal ulcer disease. Hepatogastroenterology 47 (2000) 1301-1304
47. Keatings V.M., Collins P.D., Scott D.M., and Barnes P.J. Differences in interleukin-8 and tumor necrosis factor-a in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 153 (1996) 530-534
48. Chung K.F. Cytokines in chronic obstructive pulmonary disease. Eur Respir J Suppl 34 (2001) 50-59
49. Pitsiou G., Kyriazis G., Hatzisi O., Argyropoulou P., Mavrofridis E., and Patakas D. Tumor necrosis factor-alpha serum levels, weight levels, weight loss and tissue oxygenation in chronic obstructive pulmonary disease. Respir Med 96 (2002) 594-598
50. Peterson W.L., and Graham D.Y. Helicobacter pylori. In: Feldman M., Scharschmidt B.F., and Sleisenger M.H. (Eds). Gastrointestinal and liver disease. Pathophysiology, diagnosis, management. 6th ed (1998), WB Saunders, Philadelphia 604-619
51. Tsang K.W., Lam S.K., Lam W.K., Karlberg J., Wong B.C., Yew W.W., et al. High seroprevalence of Helicobacter pylori in active bronchiectasis. Am J Respir Crit Care Med 158 (1998) 1047-1051
52. Peterson W.L., and Graham D.Y. Helicobacter pylori. In: Feldman M., Scharschmidt B.F., and Sleisenger M.H. (Eds). Gastrointestinal and liver disease. Pathophysiology, diagnosis, management. 6th ed (1998), WB Saunders, Philadelphia 604-619
53. Tsang K.W., Lam W.K., Chan K.N., Hu W., Wu A., Kwok E., et al. Helicobacter pylori seroprevalence in asthma. Respiratory medicine 94 (2000) 756-759
54. Jun Z.J., Lei Y., Shimizu Y., Dobashi K., and Mori M. Helicobacter pylori seroprevalence in patients with mild asthma. Tohoku J Exp Med 207 (2005) 287-291
55. Holmboe A.M., and Nissen-Meyer S. Gastroduodenal ulcer and pulmonary tuberculosis. Nord Med 57 (1957) 575-578
56. Filippou N., Roussos A., Tsimboukas F., Tsimogianni A., Anastasakou E., and Mavrea S. Helicobacter pylori seroprevalence in patients with pulmonary tuberculosis. J Clin Gastroenterol 34 (2002) 189
57. Mitchell H.M., Li Y.Y., Hu P.J., Liu Q., Chen M., Du G.G., et al. Epidemiology of Helicobacter pylori in southern China: identification of early childhood as the critical period for acquisition. J Infect Dis 166 (1992) 149-153
58. Sanaka M., Kuyama Y., Iwasaki M., Hanada Y., Tsuchiya A., Haida T., et al. No difference in seroprevalences of Helicobacter pylori infection between patients with pulmonary tuberculosis and those without. J Clin Gastroenterol 27 (1998) 331-334
59. Goldfeld A.E., Delgado J.C., Thim S., Bozon M.V., Uglialoro A.M., Turbay D., et al. Association of an HLA-DQ allele with clinical tuberculosis. JAMA 29 (1998) 226-228
60. Azuma T., Konishi J., Tanaka Y., Hirai M., Ito S., Kato T., et al. Contribution of HLA-DQA gene to host's response against Helicobacter pylori. Lancet 343 (1994) 542-543